Genome-wide prediction, display and refinement of binding sites with information theory-based models
© Gadiraju et al; licensee BioMed Central Ltd. 2003
Received: 07 May 2003
Accepted: 08 September 2003
Published: 08 September 2003
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact us so we can address the problem.
We present Delila-genome, a software system for identification, visualization and analysis of protein binding sites in complete genome sequences. Binding sites are predicted by scanning genomic sequences with information theory-based (or user-defined) weight matrices. Matrices are refined by adding experimentally-defined binding sites to published binding sites. Delila-Genome was used to examine the accuracy of individual information contents of binding sites detected with refined matrices as a measure of the strengths of the corresponding protein-nucleic acid interactions. The software can then be used to predict novel sites by rescanning the genome with the refined matrices.
Parameters for genome scans are entered using a Java-based GUI interface and backend scripts in Perl. Multi-processor CPU load-sharing minimized the average response time for scans of different chromosomes. Scans of human genome assemblies required 4–6 hours for transcription factor binding sites and 10–19 hours for splice sites, respectively, on 24- and 3-node Mosix and Beowulf clusters. Individual binding sites are displayed either as high-resolution sequence walkers or in low-resolution custom tracks in the UCSC genome browser. For large datasets, we applied a data reduction strategy that limited displays of binding sites exceeding a threshold information content to specific chromosomal regions within or adjacent to genes. An HTML document is produced listing binding sites ranked by binding site strength or chromosomal location hyperlinked to the UCSC custom track, other annotation databases and binding site sequences. Post-genome scan tools parse binding site annotations of selected chromosome intervals and compare the results of genome scans using different weight matrices. Comparisons of multiple genome scans can display binding sites that are unique to each scan and identify sites with significantly altered binding strengths.
Delila-Genome was used to scan the human genome sequence with information weight matrices of transcription factor binding sites, including PXR/RXRα, AHR and NF-κB p50/p65, and matrices for RNA binding sites including splice donor, acceptor, and SC35 recognition sites. Comparisons of genome scans with the original and refined PXR/RXRα information weight matrices indicate that the refined model more accurately predicts the strengths of known binding sites and is more sensitive for detection of novel binding sites.
We describe a system to identify and display significant non-coding genomic sequences that are important for transcriptional regulation and post-transcriptional mRNA processing. Our system builds on Delila , a series of programs designed to scan sets of sequence fragments (or small genomes, ie. bacterial) for potential binding sites. The regulatory sequences that are bound by proteins are detected by the tools provided with the Delila system, which defines binding sites according to Shannon information theory .
Information content is the number of choices needed to describe a sequence pattern and has units of bits . In the analysis of nucleic acid binding sites, functional site sequences are aligned and the frequencies of nucleotides at each position are used to calculate the individual information weight matrix, R i (b, l)  of each base b at position l. Computation of binding site R i (b, l) information weight matrices based upon published and laboratory-derived sites is a prerequisite to detecting and visualizing predicted binding sites with Delila-Genome. The procedures and software used to derive these matrices have been previously described [1, 4, 5] for different types of protein binding sites [6–13]. This matrix is used to scan the genome and evaluate the individual information content (R i , in bits) of potential binding sites. Functional binding sites have values > 0 bits and the consensus sequence has the maximum R i value. A single bit difference in R i value corresponds to at least a two-fold difference in binding site strength. Changes in information content resulting from mutations correspond to observed phenotypes both in vitro and in vivo [6–8, 11]; by contrast, non-deleterious polymorphisms result in nominal changes in R i . value. Therefore, scans with information weight matrices can be used to measure the relative strengths of potential binding sites throughout the genome.
Scans of eukaryotic genomes [14, 15] often require longer execution times and generate considerably larger outputs than prokaryotic genome scans  due to increased genome sizes and the quantities of sites detected. The development of Delila-Genome was motivated by the need to streamline the detection and display of sets of the most relevant binding sites in eukaryotic genomic or heteronuclear RNA sequences. Visual juxtaposition of these results with other genomic annotation facilitates the prediction and interpretation of binding sites. In order to limit the presentation of weak binding sites (with lower than average information content, ie. <<Rsequence) which can be densely distributed in both expressed and non-expressed genomic intervals, we developed visualization tools in Delila-Genome to mine relevant binding sites in gene-rich regions and to display clusters of sites with their respective information contents. Details of individual binding sites can also be presented at high resolution as sequence walkers , which depict contributions of each nucleotide to the overall information content of the site.
The number and R i values of the sites that define the information weight matrix, R i (b, l), dictate which binding sites are predicted and the corresponding strengths of these sites found in genome scans. Models based on small numbers of proven binding sites may fail to detect valid binding sites and can tend to predict R i inaccurately. Iterative selection of functional binding sites has been used to optimize [7, 8, 16] and to introduce bias  into the frequencies of each nucleotide in computing the information theory-based weight matrices of binding sites. Significant differences between information weight matrices have been determined from their respective evolutionary distance metrics (for example, see ). Delila-Genome monitors the effects of model alterations by comparing the genome scan results for pairs of information weight matrices. Although the primary application is to compare sets of binding sites with successive versions of the same weight matrix, other potential applications include determining the locations of overlapping binding sites recognized by different proteins and comparisons of binding sites detected with information models of orthologous proteins from different species.
Delila-Genome has been optimized to compute the locations of prospective transcription factor and splicing recognition sites by information theory-based analyses of recent human genome draft and finished sequences. We describe this software system, measure its performance, and illustrate the results of genome scans using visualization and post-genomic analytic tools which monitor the effects of matrix refinement on genome-wide identification of binding sites.
Delila-Genome Front End
Submission of the genome scan
A front end was developed for submission of the genome-wide or chromosomal scans and for tailoring the output to filter and view the most relevant results. A Java-based GUI tool (developed with Java Swing technology) enables submission of scans to the server. Besides the Delila books containing chromosomal sequences, the only required input file is the R i (b, l) information weight matrix (ribl) of the protein binding site. This file is output by the ri program, and the procedure for generating this file has been described . In order to assess the degree to which the computed information depends on these weights, an option is provided to modify this matrix by uploading a file containing these weights or entering them as integers on a Java form. Parameters are requested for the Delila scan program  which performs the genome scan, and promotsite (see below: Delila Genome Server), a program that produces files for displaying binding sites within or adjacent to genes. The user selects the program to execute on the server and then either fills in the parameters required by the selected program or the front-end can pull the default parameters from the server. The front end also displays all of the genome assembly versions installed on the server (at our institution: human genome versions April, 2003, November, 2002, and October, 2000). The front end validates the parameters before submission. Java socket programming is used to connect to the server.
Low resolution tools
The server generates a list of predicted binding sites as a BED-formatted file http://genome.ucsc.edu/goldenPath/help/customTrack.html which is uploaded to the appropriate human genome draft browser at the inception of the session. The name assigned to a site is a concatenation of the GenBank accession number associated with the site (described below: Delila-Genome server, promotsite), the name of R i (b, l) matrix, ie. type of site, and the strength of the site in bits. Sites are represented as a color-shaded block in the custom track of the UCSC browser. The score field of the BED file controls the degree of shading of the site, with the strongest sites being the most opaque and the weakest being the most transparent. The score used in Delila-Genome BED files is a linear scaling of the R i value. The start and end coordinates of a site correspond to the thick- and thin-ends of the BED features, respectively, so that its orientation can be visualized at high magnification. The Scandiff program generates BED files for different categories of output, each of which has a unique color coding. The genvis Perl tool selects genes with sites either within user-defined chromosomal intervals or sorted by information content from input BED files and generates HTML pages hyperlinked to the UCSC genome browser custom track. The user can either retrieve the BED files from the server and upload them to the genome browser locally, or connect to the server using X terminal software and upload them from the server to the genome browser.
By navigating the other hyperlinks on the HTML page, one can view (i) the DNA sequence of a binding site (Fig. 2C), (ii) detailed characteristics of the binding site on the UCSC genome browser custom track (Fig. 2B), (iii) GenBank (Fig. 2E) and Stanford SOURCE (Fig. 2F) relational data describing the mRNA associated with this site, and (iv) all binding sites adjacent to the accession number on the UCSC browser within a user-defined window size (Fig. 2G).
High resolution tools
The contributions of each nucleotide (in bits) to the overall individual information content of a single binding site can be at viewed at high resolution using sequence walkers (; shown in Figure 2D). A walker graphically represents the weight of each nucleotide at each position in a single possible binding site, with the height of the nucleotide indicating how well the bases match the individual information weight matrix.
To display a sequence walker, the DNA sequence containing the binding site (through a hyperlink on the HTML page) should be stored in the user's autolister directory on the server (or a Linux/Unix client running Delila). The Delila atchange script is configured to display the sequence walker by running the Delila-Genome autolist script which scans the downloaded sequence for binding sites, executes the lister program to generate a postscript image of the sequence walker, and pops up the image in a new X-window with ghostview. Longer sequences may also be retrieved, permitting walkers from multiple, adjacent binding sites and the genomic context of the binding site to be visualized.
The Delila-Genome Server
The first step in building Delila-Genome was to port the Delila individual information programs to the Linux platform. The Delila software library is distributed by the National Cancer Institute as binaries for the Sun Sparc system. Source code written in Pascal was translated to C using p2c and debugged.
The main components of the server are the scan (from Delila), promotsite, scandiff and genvis programs. The server module generally runs directly on top of the Delila system however it can be run using a reduced set of Delila binaries. Besides the scan program, the only Delila programs required by Delila-Genome are lister, mkdb, and dbbk (for displaying sequence walkers). The Delila-Genome server programs are described below.
Scan evaluates the strength (in bits) of each binding site and reports those sites whose strength (R i ) lies within a user defined range . The parameters for scan are defined in the front-end Java program. The minimum threshold R i value (R i, minimum ) is set at or above zero bits. Genome scans with an R i (b, l) matrix derived from a limited number of binding sites, n = 50 can significantly contribute to Type 1 errors (false positive detection of weak binding sites). To decrease the source of this error, R i, minimum is generally set to the R i value of the weakest binding site used to compute the weight matrix. Alternatively, sites whose Z scores or probabilities of the binding strengths fall within a user-defined range may be selected. The user also specifies which portion of the individual information matrix is scanned and which strand to evaluate (positive, negative or both). Scan can output data (locations and strengths of sites), scanfeatures (features for display with lister) and scaninst (instructions for extracting sites as Delila book files) files for each chromosome, however, only the data file is required as input to the promotsite program. Each record in the data file contains the R i values of all predicted binding sites in the genome, their respective coordinates, the Z scores of these R i values and their corresponding probabilities. Scan has numerous other features, the details of which are presented in . The Z score for user-defined matrices is based upon the mean of the distribution of scores derived from these matrices. The mean is determined first by simulating a set of binding sites based upon this weight matrix (with the ridi program ) and then computing R sequence from a book of sequences containing these sites with the encode, dalvec and rseq programs (eg. ).
Promotsite was developed to filter the output produced by scan, since these results may potentially contain large numbers of potential binding sites (>>106), many of which are distant from expressed sequences. Promotsite prunes the data file produced by scan and reports only relevant sites which are within or adjacent to expressed genomic templates. The user defines a search window either upstream or downstream (or both) relative to the beginning genomic coordinate (often the transcriptional initiation site) of each gene. The upstream and downstream window lengths may be specified independently. Promotsite modifies the data file format produced by scan so that the associated GenBank accession number is appended to the record containing the binding site (psdataop file). Typical analyses of splice sites within human coding regions selected sites up to 1 Mb downstream of the transcription initiation site in order to ensure that even the longest genes would be encompassed by these searches. We have limited the analyses of promoters to a 10 kb interval upstream (in some cases, downstream) of the transcription initiation site. However, these parameters should be set (and subsequently optimized) based upon previous experimental or published binding site studies for specific factors. For example, to comprehensively detect insulator elements bound by the protein CTCF, this window has been specified bi-directionally and increased in length (to 50 kb; not shown).
Since a site may, in some instances, fall within the search window of multiple mRNAs, the mRNA whose start position is closest to the binding site coordinate is assigned to be the associated mRNA for that site. The list of reported binding sites may also be pruned based on a range of chromosomal coordinates and by specifying particular chromosomes. Promotsite also defines a parameter known as the paralog distance. Since the same mRNA sequence may be mapped based upon its similarity to multiple genomic locations, paralogous genes on the same chromosome designated with the same mRNA accession number were distinguished from large genes containing multiple widely-dispersed exons by defining a parameter for the minimum distance between paralogous loci. Binding sites separated by less than the paralog distance are labeled with the same GenBank accession number and are considered part of the same gene, whereas sites exceeding this distance were assumed to be derived from different genes that were similar to the same GenBank accession. Typically, we set the paralog distance to 105 or 106 bp, depending upon the lengths and density of genes or gene families thought to contain relevant binding sites. Using the associated mRNA for each site, promotsite creates a BED-formatted file that can be uploaded as a custom track on the UCSC human genome browser http://genome.ucsc.edu.
The execution time of scan depends on the length of the chromosome and the nucleotide length, l, of the R i (b, l) weight matrix that defines the binding site. For hardware platforms with multiple computational nodes, the server can distribute scan and promotsite runs for each chromosome between these nodes so that the execution time over the whole genome is minimized. As l is constant over the whole genome, this load-balancing is based upon the length of each chromosome. Since execution times are generally several hours, the server informs the user of job completion by email.
Post-genome scan analysis
Inaccuracies in the genome draft coordinates of splice junction recognition sites motivated the development of an automated strategy to select correctly localized splice sites. Information weight matrices were iteratively recomputed from the set of sites with positive R i values . More recently, we have built models of transcription factor binding sites by cyclical refinement of weight matrices based on published data from established regulated gene targets, supplemented with binding sites in these genes predicted by information theory and experimentally validated [7, 8]. With Delila-Genome, potential novel binding sites identified can be verified in the laboratory and included in subsequent refinements of the weight matrix.
Total binding site counts based on genome scans of promoters with PXR/RXRα information weight matrices
Numbers of sites in each category
Confidence intervals +
(A ∩ B) S ~
(A ∩ B) I @
Threshold (Δ R i , bits)
(A ∩ B) S
(A ∩ B) I
Threshold (± S.D.)
(A ∩ B) S
(A ∩ B) I
The criteria of measuring changes in binding site strength is dictated by the stage of model refinement (see below). Absolute comparisons of R i values are not as meaningful at early stages of refinement, since addition of experimentally-defined binding sites to an information model can substantially alter the distribution of R i values of the binding sites that underlie these weight matrices. At early stages of refinement, the information models are based on fewer binding sites, resulting in larger confidence intervals for individual R i values. Comparisons of R i values based upon the sizes of confidence intervals are therefore not as reliable measure of significant change in information as changes in their respective Z scores.
Upon model convergence, the proportion of sites in successive models with significant differences in information content should be quite small (S/ [S+I] (S = significant, I = insignificant) for confidence intervals of = 3 S.D. The proportion of sites common to both models relative to discordant sites found in only one model ([S+I] / [A-B] + [B-A]), should stabilize as successive versions of the information weight matrix are refined.
Results and Discussion
We tested the Delila-Genome system by scanning the human genome draft sequence (November, 2002) with information weight matrices developed from human transcription factor binding sites (PXR/RXRα [pregnane-X receptor], NF-kB [p50/p65 heterodimer], and AHR [aryl hydrocarbon receptor]) and with models of sites required for post-transcriptional processing of heteronuclear RNA (donor and acceptor splice sites, and the SR protein, SC35). All binding site sequences were derived from published studies, and in some instances (PXR/RXRα, NF-kB), supplemented by binding sites validated in our laboratory [7, 8]. The information weight matrices were derived with the Delila system using previously established procedures .
Performance metrics for genome scans
Execution time (hrs) *
Number of sites found^
Weight matrix version
Num. sites in Model
R i ≥ R i,min
R i ≥ R Seq
Unique Promoters with R i ≥ R seq
Promoters with multiple sites (%) R i ≥ R seq
Analysis of the splice acceptor and donor runs required a modification of the published genome sequence. In the original genome drafts, a very large number of binding sites (>>108) were initially found. Many of these sites were composed of long runs of undefined polynucleotides (ie. = N(10)) in heterochromatin and in gaps in the draft sequence. The Delila program defaults to adenine in these cases, and in the case of splice acceptor sites, these substitutions generated sites comprised of polyadenine, which itself has an R i value exceeding the user-defined threshold (2.4 bits; R i, minimum ). These runs exceeded our available disk storage, and to reduce the quantity of false positive sites, we generated and substituted random nucleotides for every sequence of undefined polynucleotides = 10 bp in length. Our previous studies have shown that sequence randomization produces fewer than 2% of binding sites with R i values above zero bits , and none above the minimum R i threshold value . The genome scans of the substituted genome sequences with splice donor and acceptor R i (b, l) weight matrices were completed in 10.5 and 14.5 hours, respectively.
Visualization of binding sites in subgenomic intervals
We have found that uploads of large BED files of binding sites to the remote UCSC genome browser can be time-consuming and sometimes fail. The BED file for all binding sites found with PXR/RXRα Model 4, for example, is ~ 30 MB and required 5–10 minutes to upload. Furthermore, the large numbers of sites found with some information weight matrices (eg. splice donor and acceptor sites; 254 Mb for acceptor sites on chromosome 1 alone) produce BED file sizes exceeding browser/server limits. We therefore created and viewed subsets of binding sites for genomic regions of specific interest with the genvis tool.
Figure 2 depicts the HTML page generated by genvis, containing a partial list of binding sites on chromosome 1 for the PXR/RXRα model 4 R i (b, l) weight matrix. The websites linked to this page are also shown (but have been resized or truncated) to reflect only the important details of each. When the HTML page is initially loaded, a window for the UCSC browser pops up. The BED file is uploaded using a button in this window upon selecting the appropriate version of the genome draft at the UCSC website. When the genome browser target links (entries in the R i , Seq and UCSC Browser columns) are activated, the genome browser displays the information based on this uploaded file.
The second row of the HTML table in Figure 2 corresponds to the binding site associated with the GenBank Accession L13278. This is a strong binding site (R i value of ~ 20.1 bits) which is hyper-linked to the custom track detail in the genome browser. This track detail page indicates the size of the site and the orientation of the recognition sequence on the draft genome sequence. The user can obtain the DNA sequence of the site either from from the Seq cell in the HTML table or from the corresponding custom track detail. The pop up sequence walker indicates the relative contributions of each nucleotide in the site .
The linked GenBank and SOURCE database entries indicate that accession L13278 encodes the zeta-crystallin/quinone reductase gene. We selected this example to illustrate that Delila-Genome can be used to potentially discover novel transcriptional regulatory targets, since this gene has not been previously demonstrated to be regulated by PXR/RXRα. The SOURCE entry is based on a dynamic collection and compilation of gene data from many scientific databases associated with the GenBank accession, whereas the GenBank entry, in some instances, is not curated and guaranteed only to contain the corresponding sequence. The SOURCE entry also indicates other information such as the aliases for the gene name, the locus link designation, expression profile, etc.
The UCSC genome browser entry displays the binding site custom track and sequences in the proximity of the associated GenBank accession. The coordinates delineate a display window concordant with the search window defined in promotsite for generating the list of binding sites given in the HTML page. In Figure 2, the predicted site is 1112 bp upstream of L13278 and ~ 7.2 kb upstream of an as yet uncharacterized gene corresponding to both AK098237 and BC009514. Although we cannot exclude the possibility that this site regulates the gene encoded by AK098237/BC009514, its closer proximity to the zeta-crystallin gene and the common orientation of both the site and gene on the antisense strand suggests that this site may function as a potential transcriptional enhancer element. There are no other predicted binding sites in the vicinity of this gene.
Comparison of genome scans produced from successive transcription factor information weight matrices
The results of genome scans with successive refinements of PXR/RXRα information weight matrices were compared using scandiff. The refinement procedure was validated by detecting binding sites in well-established PXR/RXRα target genes. Initial models based on published sites were used to scan target genes that were known to be induced by PXR/RXRα binding, but where additional sites had not been previously identified. Sites detected in these scans were assayed for binding to PXR/RXRα and those found to bind were incorporated in subsequent rounds of refinement.
The genvis program was used to display scandiff results for CYP3A4, which is a single gene known to be regulated by PXR/RXRα (Figure 3). BED-custom tracks of this gene for scans of the initial and second PXR/RXRα models (1 and 2) are indicated. Both information models recognize experimentally-verified binding sites [21, 22]: a strong, potential proximal enhancer binding site (custom track M18907_pxr_R17) 204 bp upstream of the transcription initiation site and a cluster of distal enhancer elements 7.2–7.8 kb upstream. Model 1 identified a 7 bit site (AF182273_pxr_R7) in the first intron, which is absent in the scan of model 2. However, model 2 also identifies an additional site (M18907_pxr_R7) within the distal enhancer cluster, which is consistent with the possibility that Model 2 more specifically recognizes promoter binding sites. Similar results were obtained confirming detection of experimentally-defined binding sites in the promoters of other PXR/RXRα regulated genes (CYP3A7, CYP2B6; results not shown) induced by this transcription factor.
Scandiff also produces a summary statistics file which can be used to monitor the progress of information theory-based model refinement. The following example indicates how the results of complete genome scans with four successive PXR/RXRα R i (b, l) matrices can be interpreted from these summaries (each successive model is based on increasing numbers of experimentally validated binding sites; Table 1). The tables indicate the differences in the number of predicted binding sites in each category of these models. By selecting high thresholds for either ΔR i values, Δ Z scores or confidence intervals, it is possible to identify binding sites with the most significant model-to-model changes. The following analysis is based on changes in information content of at least 3 bits (ΔR i ), Z score differences of = 1, and confidence intervals = 3 standard deviations, ie. 95%.
Newly identified sites (B-A) predicted with model 2 are 3.8 fold more abundant than those found only with model 1. Scanning the genome with model 3 (vs. model 2) resulted in an even greater disproportionate distribution of unique sites (9.2 fold). This trend continues in model 4, but the fraction of novel binding sites is decreased (2.4 fold). The findings indicate that increasing the diversity of the sequences underlying the matrix affects which binding sites are found in the genome scan. It is apparent that the PXR/RXRα weight matrix has not converged, since large numbers of novel sites continue to be found with successive information models.
Only a modest fraction of sites (S/ [S+I]; S = significant, I = insignificant) exhibit the largest significant changes in binding site strength (ΔR i = 3 bits; ranging from 3–11%), regardless of which pair of scans are analyzed. Most changes in information content are = 2 bits. As ΔR i values give no indication of the strengths of the sites that have changed (only the magnitude of those changes), we also cataloged significant changes by comparing the Z scores of the same binding sites found by successive models. The most stringent test (Δ Z = 1) revealed that the transition from model 2 to model 3 produced the largest proportion of significant changes (48% of sites; n = 48,657), in comparison with more modest changes in Z score from models 1 to 2 (0.8%) and models 3 to 4 (2.5%). We interpret these results to indicate that model 3 may have altered the strengths of binding sites at outlying R i values to a greater extent than the transitions either from models 1 to 2 or from models 3 to 4.
Binding sites that are added to the models in subsequent rounds of experimental refinement have increasingly diverse sequences, resulting in lower measures of R sequence and therefore detect additional predicted sites. Shorter binding sites, such as those recognized by AHR, with lower R sequence values, are predicted to be even more abundant. The vast majority of the newly detected binding sites are considered "weak" (R i <<R sequence ; Table 2). The lower threshold R i value of binding sites reported by scan is typically set to the strength of the weakest binding site used to define the information weight matrix. The confidence intervals on binding sites with low R i values are still fairly large [see Appendix to reference 11], and some of these sites may turn out to have R i < 0 bits. In any case, the affinities for sites with low R i values, especially those ~ R i, minimum are likely to be negligible and may not be detectable experimentally . Nevertheless, the increased sequence diversity introduced by these refinement procedures augments the dynamic range of site binding strengths found with later versions of refined models. The increased sequence diversity affects the frequencies of the nucleotides underlying the weight matrix and can significantly alter the information contents of predicted "strong" sites .
Additional gene promoters are found with successive PXR/RXRα models (Table 1). In each pairwise comparison of information models, novel binding sites detected by the later model substantially outnumbered unique sites found only by the earlier model (by 4 to 11.2 fold). Nevertheless, it is encouraging that the increased number of genes containing these binding sites does not proportionally increase with the numbers of binding sites, which suggests that the subsequent models are predicting additional sites in the same genes. This is not surprising, since multiple PXR/RXRα enhancer binding elements with "moderate-to-strong" R i values have been documented in known targets of this transcription factor, including several CYP3A gene family members. We examined the distributions of such sites in genome scans of promoters with the different PXR/RXRα weight matrices.
The "moderate-to-strong" binding sites in the genome-wide promoter scans (R i >R sequence ; Table 2) are a small percentage of all sites detected (0.06 % in Model 1, increasing to 0.5 % in Model 4). The refinement procedure may improve the sensitivity of detecting such sites. PXR/RXRα models 1 and 2 actually detect fewer of these sites in gene promoters (and genes) than the numbers of genes that exhibit changes in expression by microarray studies [21, 22], suggesting that these models predict fewer binding sites, and consequently fewer target genes than expected. In subsequent models, increasingly higher frequencies of multiplex sites are found in the same promoters (8% in Model 1 versus 16% in Model 4). This degree of redundancy (in Model 4) substantially exceeds the expected frequency of promoters with multiple binding sites, and the information required to find these sites in the genome (R frequency ~ 4 bits). We also find that multiplex binding sites within promoters recognized by transcription factors with smaller footprints are considerably more frequent (NF-κB p50/p65 and AHR), as expected from their lower R sequence values.
Delila-Genome can be used to scan eukaryotic genomes with information theory-based models for transcription factor and post-transcriptional protein binding sites and displays the most relevant sites. Complete scans of human genome draft sequences with information-weight matrices of transcription factor binding sites (PXR/RXRα, AHR and NF-κB p50/p65) and sequences required for mRNA splicing (donor, acceptor, and SC35 splicing enhancer protein binding sites) were completed within several hours on small Linux clusters. Binding sites can be visualized at either high or low sequence resolution juxtaposed with other genome annotation. The software can also be used to compare the distributions of predicted sites in multiple or successive binding site models. Refinement of successive binding site models should enable more accurate and specific predictions of site strength, which in turn, may facilitate discovery of novel regulatory gene targets and assist in the prediction of mRNA splicing patterns.
Availability and Requirements
Project Name: Delila-Genome
Project Home Page: http://www.sice.umkc.edu/~roganp/Information/delgen.html
Server – Linux; can be ported to Unix/Solaris with little or no modification.
Client [Front end] – Any system with JRE (Java Runtime Environment) 1.4 or higher installed
Client [Front end] – Java
Other requirements:. Individual information program package (for details, see http://www.lecb.ncifcrf.gov/~toms/walker/iipp.html)
License: Delila-Genome is deposited at http://www.bioinformatics.org under GNU GPL. The Individual Information programs are available from the National Cancer Institute via transfer agreements (see http://www.lecb.ncifcrf.gov/~toms/contacts.html). Linux binaries and the source code of the Delila programs are available to NCI-authorized users from the authors.
Any restrictions to use by non-academics: None
Descriptions of additional data files
A package of Delila-Genome software and documentation and Delila books of the human genome sequence assembly (April 2003) are available at http://www.sice.umkc.edu/~roganp/Information/delgen.html. Examples of HTML pages produced by Delila-Genome with corresponding BED custom tracks can also be downloaded from this website.
This work was sponsored by grant ES 10855 from the National Institute of Environmental Health. We are grateful to Tom Schneider and Joan Knoll for their valuable comments on the manuscript. We thank Information Services at the University of Missouri-Kansas City for access to the Mosix cluster.
- Schneider TD, Stormo GD, Haemer JS, Gold L: A design for computer nucleic-acid-sequence storage, retrieval, and manipulation. Nucleic Acids Res 1982, 10: 3013–3024.PubMed CentralView ArticlePubMedGoogle Scholar
- Shannon CE: A mathematical theory of communication. Bell System Technical Journal 1948, 27: 379–423 and 623–656.View ArticleGoogle Scholar
- Schneider TD: Sequence logos, machine/channel capacity, Maxwell's demon, and molecular computers: a review of the theory of molecular machines. Nanotechnology 1994, 5: 1–18. 10.1088/0957-4484/5/1/001View ArticleGoogle Scholar
- Schneider TD: Information content of individual genetic sequences. J Theor Biol 1997, 189: 427–441. 10.1006/jtbi.1997.0540View ArticlePubMedGoogle Scholar
- Schneider TD: Sequence walkers: a graphical method to display how binding proteins interact with DNA or RNA sequences. Nucleic Acids Res 1997, 25: 4408–4415. 10.1093/nar/25.21.4408PubMed CentralView ArticlePubMedGoogle Scholar
- Rogan PK, Faux BM, Schneider TD: Information analysis of human splice site mutations. Hum Mutat 1998, 12: 153–171. 10.1002/(SICI)1098-1004(1998)12:3<153::AID-HUMU3>3.3.CO;2-OView ArticlePubMedGoogle Scholar
- Hurwitz I, Svojanovsky S, Leeder JS, Rogan PK: Modeling differential binding of NF-kB p50 to a CYP2D6 promotor variant by information theory [abstract]. American Journal of Human Genetics 2001, 69: s476.Google Scholar
- Rogan PK, Svojanovsky S, Hurwitz I, Schneider TD, Leeder JS: Modeling splice site and transcription factor binding site variation by information theory [abstract]. American Journal of Human Genetics 2002, 71: s333.Google Scholar
- Vyhlidal CA, Rogan PK, Leeder JS: Modeling PXR/RXR Binding Using Information Theory [abstract]. 7th Annual Meeting of the International Society for Study of Xenobiotics 2002.Google Scholar
- Shultzaberger RK, Bucheimer RE, Rudd KE, Schneider TD: Anatomy of Escherichia coli ribosome binding sites. J Mol Biol 2001, 313: 215–228. 10.1006/jmbi.2001.5040View ArticlePubMedGoogle Scholar
- Rogan PK, Svojanovsky S, Leeder JS: Information theory-based analysis of CYP2C19, CYP2D6 and CYP3A5 splicing mutations. Pharmacogenetics 2003, 13: 207–218. 10.1097/00008571-200304000-00005View ArticlePubMedGoogle Scholar
- Hengen PN, Bartram SL, Stewart LE, Schneider TD: Information analysis of Fis binding sites. Nucleic Acids Res 1997, 25: 4994–5002. 10.1093/nar/25.24.4994PubMed CentralView ArticlePubMedGoogle Scholar
- Zheng M, Doan B, Schneider TD, Storz G: OxyR and SoxRS regulation of fur. J Bacteriol 1999, 181: 4639–4643.PubMed CentralPubMedGoogle Scholar
- Berman BP, Nibu Y, Pfeiffer BD, Tomancak P, Celniker SE, Levine M, Rubin GM, Eisen MB: Exploiting transcription factor binding site clustering to identify cis-regulatory modules involved in pattern formation in the Drosophila genome. Proc Natl Acad Sci U S A 2002, 99: 757–762. 10.1073/pnas.231608898PubMed CentralView ArticlePubMedGoogle Scholar
- Rebeiz M, Reeves NL, Posakony JW: SCORE: a computational approach to the identification of cis-regulatory modules and target genes in whole-genome sequence data. Site clustering over random expectation. Proc Natl Acad Sci U S A 2002, 99: 9888–9893. 10.1073/pnas.152320899PubMed CentralView ArticlePubMedGoogle Scholar
- Lund M, Tange TO, Dyhr-Mikkelsen H, Hansen J, Kjems J: Characterization of human RNA splice signals by iterative functional selection of splice sites. RNA 2000, 6: 528–544. 10.1017/S1355838200992033PubMed CentralView ArticlePubMedGoogle Scholar
- Shultzaberger RK, Schneider TD: Using sequence logos and information analysis of Lrp DNA binding sites to investigate discrepanciesbetween natural selection and SELEX. Nucleic Acids Res 1999, 27: 882–887. 10.1093/nar/27.3.882PubMed CentralView ArticlePubMedGoogle Scholar
- Schneider TD: Delila programs documentation. http://www.lecb.ncifcrf.gov/~toms/delila/delilaprograms.html 2003.Google Scholar
- Stephens RM, Schneider TD: Features of spliceosome evolution and function inferred from an analysis of the information at human splice sites. J Mol Biol 1992, 228: 1124–1136.View ArticlePubMedGoogle Scholar
- Schneider TD: Measuring molecular information. J Theor Biol 1999, 201: 87–92. 10.1006/jtbi.1999.1012View ArticlePubMedGoogle Scholar
- Gerhold D, Lu M, Xu J, Austin C, Caskey CT, Rushmore T: Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays. Physiol Genomics 2001, 5: 161–170.PubMedGoogle Scholar
- Rae JM, Johnson MD, Lippman ME, Flockhart DA: Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays. J Pharmacol Exp Ther 2001, 299: 849–857.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.